CHIRON VITRASERT TIME TO PROGRESSION IS 194 DAYS IN PHASE III TRIAL; OPHTHALMIC IMPLANT RECOMMENDED FOR APPROVAL BY FDA ADVISORY COMMITTEE

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".